Metagil-GM2
Composition: Glimepiride 2 mg + Metformin 500 mg (Sustained Release) Bilayered
Metagil GM2 combines Glimepiride 2 mg with Metformin SR 500 mg for stronger control of Type 2 Diabetes. This combination works by improving insulin response after meals and reducing overall glucose levels throughout the day. Metagil GM2 is commonly prescribed when lower-strength therapies are insufficient, and it helps maintain stable sugar levels with long-lasting action due to its sustained-release formulation.
Uses:
- Type 2 Diabetes requiring higher-dose therapy
- Reduction of fasting and post-meal blood glucose
- Improved HbA1c control
Side Effects:
- Low blood sugar
- Headache, dizziness
- Stomach discomfort
- Rare: lactic acidosis
Other Details:
- Should be taken with food
- Avoid alcohol to reduce risk of lactic acidosis
- Regular sugar monitoring is important
